New Results
Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug design
Wioletta Rut, Katarzyna Groborz, Linlin Zhang, Xinyuanyuan Sun, Mikolaj Zmudzinski, View ORCID ProfileRolf Hilgenfeld, Marcin Drag
doi: https://doi.org/10.1101/2020.03.07.981928
Wioletta Rut
aDepartment of Chemical Biology and Bioimaging, Wroclaw University of Science and Technology, Wyb. Wyspianskiego 27, 50-370 Wroclaw, Poland
Katarzyna Groborz
aDepartment of Chemical Biology and Bioimaging, Wroclaw University of Science and Technology, Wyb. Wyspianskiego 27, 50-370 Wroclaw, Poland
Linlin Zhang
bInstitute of Biochemistry, Center for Structural and Cell Biology in Medicine, University of Luebeck, Ratzeburger Allee 160, 23562 Luebeck, Germany
cGerman Center for Infection Research (DZIF), Hamburg-Luebeck-Borstel-Riems Site, University of Luebeck, 23562 Luebeck, Germany
Xinyuanyuan Sun
bInstitute of Biochemistry, Center for Structural and Cell Biology in Medicine, University of Luebeck, Ratzeburger Allee 160, 23562 Luebeck, Germany
cGerman Center for Infection Research (DZIF), Hamburg-Luebeck-Borstel-Riems Site, University of Luebeck, 23562 Luebeck, Germany
Mikolaj Zmudzinski
aDepartment of Chemical Biology and Bioimaging, Wroclaw University of Science and Technology, Wyb. Wyspianskiego 27, 50-370 Wroclaw, Poland
Rolf Hilgenfeld
bInstitute of Biochemistry, Center for Structural and Cell Biology in Medicine, University of Luebeck, Ratzeburger Allee 160, 23562 Luebeck, Germany
cGerman Center for Infection Research (DZIF), Hamburg-Luebeck-Borstel-Riems Site, University of Luebeck, 23562 Luebeck, Germany
Marcin Drag
aDepartment of Chemical Biology and Bioimaging, Wroclaw University of Science and Technology, Wyb. Wyspianskiego 27, 50-370 Wroclaw, Poland
![Loading Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
- Supplemental[supplements/981928_file02.pdf]
Posted March 08, 2020.
Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug design
Wioletta Rut, Katarzyna Groborz, Linlin Zhang, Xinyuanyuan Sun, Mikolaj Zmudzinski, Rolf Hilgenfeld, Marcin Drag
bioRxiv 2020.03.07.981928; doi: https://doi.org/10.1101/2020.03.07.981928
Subject Area
Subject Areas
- Biochemistry (13747)
- Bioengineering (10482)
- Bioinformatics (33289)
- Biophysics (17168)
- Cancer Biology (14241)
- Cell Biology (20184)
- Clinical Trials (138)
- Developmental Biology (10899)
- Ecology (16072)
- Epidemiology (2067)
- Evolutionary Biology (20393)
- Genetics (13438)
- Genomics (18687)
- Immunology (13812)
- Microbiology (32254)
- Molecular Biology (13420)
- Neuroscience (70250)
- Paleontology (528)
- Pathology (2202)
- Pharmacology and Toxicology (3753)
- Physiology (5902)
- Plant Biology (12054)
- Synthetic Biology (3376)
- Systems Biology (8187)
- Zoology (1847)